APO Research
Talk to an analyst

APO RESEARCH · REPORT

Normal Saline for Parenteral Use

Normal saline is a mixture of salt and water. It is called normal because its salt concentration is similar to tears, blood and other body fluids (0.9% saline). It is also called isotonic solution. It has a number of uses in medicine. By injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis. It is also used to dilute other medications to be given by injection.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Normal saline is a mixture of salt and water. It is called normal because its salt concentration is similar to tears, blood and other body fluids (0.9% saline). It is also called isotonic solution. It has a number of uses in medicine. By injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis. It is also used to dilute other medications to be given by injection.

This report studies Normal Saline for Parenteral Use market in hospital and clinics, and usually refers to Sodium Chloride Injection

Selected research

Industry Growth & Trends

Global Normal Saline for Parenteral Use Industry Growth and Trends Forecast to 2032

31 December 2025103 pages

Choose your research edition.

Industry ResearchNormal Saline for Parenteral Use Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Normal Saline for Parenteral Use Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Normal Saline for Parenteral Use Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Normal Saline for Parenteral Use Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Normal Saline for Parenteral Use Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Normal saline is a mixture of salt and water. It is called normal because its salt concentration is similar to tears, blood and other body fluids (0.9% saline). It is also called isotonic solution. It has a number of uses in medicine. By injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis. It is also used to dilute other medications to be given by injection.

This report studies Normal Saline for Parenteral Use market in hospital and clinics, and usually refers to Sodium Chloride Injection

At present, Baxter, Kelun Group, B. Braun, Fresenius Kabi and SSY Group are the top five manufacturers of gastrointestinal saline in the world, with a total market share of more than 45%.They are also the world's largest companies by sales.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Normal Saline for Parenteral Use market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Normal Saline for Parenteral Use market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Normal Saline for Parenteral Use market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Normal Saline for Parenteral Use.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Normal Saline for Parenteral Use market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Normal Saline for Parenteral Use Market by Company

Baxter

Pfizer

B. Braun

ICU Medical

Fresenius Kabi

Otsuka

Kelun Group

CR Double-Cran

SSY Group

Cisen Pharmaceutical

Denis Chem Lab Limited

Shree Krishnakeshav Laboratories

Pharmally International

Normal Saline for Parenteral Use Segment by Type

Flexible Bag

Plastic Bottles

Glass Bottles

Normal Saline for Parenteral Use Segment by Application

Intramuscular Injection

Intravenous Injection

Others

Normal Saline for Parenteral Use Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Normal Saline for Parenteral Use market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Normal Saline for Parenteral Use and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Normal Saline for Parenteral Use.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Normal Saline for Parenteral Use manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Normal Saline for Parenteral Use in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Flexible Bag Table 2. Major Company of Plastic Bottles Table 3. Major Company of Glass Bottles Table 4. Global Normal Saline for Parenteral Use Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Normal Saline for Parenteral Use Sales by Type (2021-2026) & (M Units) Table 6. Global Normal Saline for Parenteral Use Sales Market Share in Volume by Type (2021-2026) Table 7. Global Normal Saline for Parenteral Use Sales by Type (2021-2026) & (US$ Million) Table 8. Global Normal Saline for Parenteral Use Sales Market Share in Value by Type (2021-2026) Table 9. Global Normal Saline for Parenteral Use Price by Type (2021-2026) & (US$/K Unit) Table 10. Global Normal Saline for Parenteral Use Sales by Type (2027-2032) & (M Units) Table 11. Global Normal Saline for Parenteral Use Sales Market Share in Volume by Type (2027-2032) Table 12. Global Normal Saline for Parenteral Use Sales by Type (2027-2032) & (US$ Million) Table 13. Global Normal Saline for Parenteral Use Sales Market Share in Value by Type (2027-2032) Table 14. Global Normal Saline for Parenteral Use Price by Type (2027-2032) & (US$/K Unit) Table 15. North America Normal Saline for Parenteral Use Sales by Type (2021-2026) & (M Units) Table 16. North America Normal Saline for Parenteral Use Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Normal Saline for Parenteral Use Sales by Type (2021-2026) & (M Units) Table 18. Europe Normal Saline for Parenteral Use Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Normal Saline for Parenteral Use Sales by Type (2021-2026) & (M Units) Table 20. Asia-Pacific Normal Saline for Parenteral Use Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Normal Saline for Parenteral Use Sales by Type (2021-2026) & (M Units) Table 22. Latin America Normal Saline for Parenteral Use Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Normal Saline for Parenteral Use Sales by Type (2021-2026) & (M Units) Table 24. Middle East and Africa Normal Saline for Parenteral Use Sales by Type (2021-2026) & (US$ Million) Table 25. Normal Saline for Parenteral Use Industry Trends Table 26. Normal Saline for Parenteral Use Industry Drivers Table 27. Normal Saline for Parenteral Use Industry Opportunities and Challenges Table 28. Normal Saline for Parenteral Use Industry Restraints Table 29. Global Normal Saline for Parenteral Use Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Normal Saline for Parenteral Use Revenue Market Share by Company (2021-2026) Table 31. Global Normal Saline for Parenteral Use Sales by Company (2021-2026) & (M Units) Table 32. Global Normal Saline for Parenteral Use Sales Share by Company (2021-2026) Table 33. Global Normal Saline for Parenteral Use Market Price by Company (2021-2026) & (US$/K Unit) Table 34. Global Normal Saline for Parenteral Use Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Normal Saline for Parenteral Use Major Company Production Sites and Headquarters Table 36. Global Normal Saline for Parenteral Use Company, Product Type & Application Table 37. Global Normal Saline for Parenteral Use Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Normal Saline for Parenteral Use by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Normal Saline for Parenteral Use Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Normal Saline for Parenteral Use Sales by Region (2021-2026) & (M Units) Table 42. Global Normal Saline for Parenteral Use Sales Market Share in Volume by Region (2021-2026) Table 43. Global Normal Saline for Parenteral Use Sales by Region (2021-2026) & (US$ Million) Table 44. Global Normal Saline for Parenteral Use Sales Market Share in Value by Region (2021-2026) Table 45. Global Normal Saline for Parenteral Use Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 46. Global Normal Saline for Parenteral Use Sales by Region (2027-2032) & (M Units) Table 47. Global Normal Saline for Parenteral Use Sales Market Share in Volume by Region (2027-2032) Table 48. Global Normal Saline for Parenteral Use Sales by Region (2027-2032) & (US$ Million) Table 49. Global Normal Saline for Parenteral Use Sales Market Share in Value by Region (2027-2032) Table 50. Global Normal Saline for Parenteral Use Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2027-2032) Table 51. Global Normal Saline for Parenteral Use Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Normal Saline for Parenteral Use Sales by Application (2021-2026) & (M Units) Table 53. Global Normal Saline for Parenteral Use Sales Market Share in Volume by Application (2021-2026) Table 54. Global Normal Saline for Parenteral Use Sales by Application (2021-2026) & (US$ Million) Table 55. Global Normal Saline for Parenteral Use Sales Market Share in Value by Application (2021-2026) Table 56. Global Normal Saline for Parenteral Use Price by Application (2021-2026) & (US$/K Unit) Table 57. Global Normal Saline for Parenteral Use Sales by Application (2027-2032) & (M Units) Table 58. Global Normal Saline for Parenteral Use Sales Market Share in Volume by Application (2027-2032) Table 59. Global Normal Saline for Parenteral Use Sales by Application (2027-2032) & (US$ Million) Table 60. Global Normal Saline for Parenteral Use Sales Market Share in Value by Application (2027-2032) Table 61. Global Normal Saline for Parenteral Use Price by Application (2027-2032) & (US$/K Unit) Table 62. North America Normal Saline for Parenteral Use Sales by Application (2021-2026) & (M Units) Table 63. North America Normal Saline for Parenteral Use Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Normal Saline for Parenteral Use Sales by Application (2021-2026) & (M Units) Table 65. Europe Normal Saline for Parenteral Use Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Normal Saline for Parenteral Use Sales by Application (2021-2026) & (M Units) Table 67. Asia-Pacific Normal Saline for Parenteral Use Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Normal Saline for Parenteral Use Sales by Application (2021-2026) & (M Units) Table 69. Latin America Normal Saline for Parenteral Use Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Normal Saline for Parenteral Use Sales by Application (2021-2026) & (M Units) Table 71. Middle East and Africa Normal Saline for Parenteral Use Sales by Application (2021-2026) & (US$ Million) Table 72. Baxter Company Information Table 73. Baxter Business Overview Table 74. Baxter Normal Saline for Parenteral Use Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 75. Baxter Normal Saline for Parenteral Use Product Portfolio Table 76. Baxter Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Normal Saline for Parenteral Use Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 80. Pfizer Normal Saline for Parenteral Use Product Portfolio Table 81. Pfizer Recent Development Table 82. B. Braun Company Information Table 83. B. Braun Business Overview Table 84. B. Braun Normal Saline for Parenteral Use Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 85. B. Braun Normal Saline for Parenteral Use Product Portfolio Table 86. B. Braun Recent Development Table 87. ICU Medical Company Information Table 88. ICU Medical Business Overview Table 89. ICU Medical Normal Saline for Parenteral Use Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 90. ICU Medical Normal Saline for Parenteral Use Product Portfolio Table 91. ICU Medical Recent Development Table 92. Fresenius Kabi Company Information Table 93. Fresenius Kabi Business Overview Table 94. Fresenius Kabi Normal Saline for Parenteral Use Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 95. Fresenius Kabi Normal Saline for Parenteral Use Product Portfolio Table 96. Fresenius Kabi Recent Development Table 97. Otsuka Company Information Table 98. Otsuka Business Overview Table 99. Otsuka Normal Saline for Parenteral Use Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 100. Otsuka Normal Saline for Parenteral Use Product Portfolio Table 101. Otsuka Recent Development Table 102. Kelun Group Company Information Table 103. Kelun Group Business Overview Table 104. Kelun Group Normal Saline for Parenteral Use Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 105. Kelun Group Normal Saline for Parenteral Use Product Portfolio Table 106. Kelun Group Recent Development Table 107. CR Double-Cran Company Information Table 108. CR Double-Cran Business Overview Table 109. CR Double-Cran Normal Saline for Parenteral Use Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 110. CR Double-Cran Normal Saline for Parenteral Use Product Portfolio Table 111. CR Double-Cran Recent Development Table 112. SSY Group Company Information Table 113. SSY Group Business Overview Table 114. SSY Group Normal Saline for Parenteral Use Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 115. SSY Group Normal Saline for Parenteral Use Product Portfolio Table 116. SSY Group Recent Development Table 117. Cisen Pharmaceutical Company Information Table 118. Cisen Pharmaceutical Business Overview Table 119. Cisen Pharmaceutical Normal Saline for Parenteral Use Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 120. Cisen Pharmaceutical Normal Saline for Parenteral Use Product Portfolio Table 121. Cisen Pharmaceutical Recent Development Table 122. Denis Chem Lab Limited Company Information Table 123. Denis Chem Lab Limited Business Overview Table 124. Denis Chem Lab Limited Normal Saline for Parenteral Use Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 125. Denis Chem Lab Limited Normal Saline for Parenteral Use Product Portfolio Table 126. Denis Chem Lab Limited Recent Development Table 127. Shree Krishnakeshav Laboratories Company Information Table 128. Shree Krishnakeshav Laboratories Business Overview Table 129. Shree Krishnakeshav Laboratories Normal Saline for Parenteral Use Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 130. Shree Krishnakeshav Laboratories Normal Saline for Parenteral Use Product Portfolio Table 131. Shree Krishnakeshav Laboratories Recent Development Table 132. Pharmally International Company Information Table 133. Pharmally International Business Overview Table 134. Pharmally International Normal Saline for Parenteral Use Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 135. Pharmally International Normal Saline for Parenteral Use Product Portfolio Table 136. Pharmally International Recent Development Table 137. North America Normal Saline for Parenteral Use Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 138. North America Normal Saline for Parenteral Use Sales by Country (2021-2026) & (M Units) Table 139. North America Normal Saline for Parenteral Use Sales Market Share by Country (2021-2026) Table 140. North America Normal Saline for Parenteral Use Sales Forecast by Country (2027-2032) & (M Units) Table 141. North America Normal Saline for Parenteral Use Sales Market Share Forecast by Country (2027-2032) Table 142. North America Normal Saline for Parenteral Use Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Normal Saline for Parenteral Use Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Normal Saline for Parenteral Use Market Share by Country (2021-2026) Table 145. North America Normal Saline for Parenteral Use Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Normal Saline for Parenteral Use Market Share Forecast by Country (2027-2032) Table 147. Europe Normal Saline for Parenteral Use Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 148. Europe Normal Saline for Parenteral Use Sales by Country (2021-2026) & (M Units) Table 149. Europe Normal Saline for Parenteral Use Sales Market Share by Country (2021-2026) Table 150. Europe Normal Saline for Parenteral Use Sales Forecast by Country (2027-2032) & (M Units) Table 151. Europe Normal Saline for Parenteral Use Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Normal Saline for Parenteral Use Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Normal Saline for Parenteral Use Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Normal Saline for Parenteral Use Market Share by Country (2021-2026) Table 155. Europe Normal Saline for Parenteral Use Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Normal Saline for Parenteral Use Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Normal Saline for Parenteral Use Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Normal Saline for Parenteral Use Sales by Country (2021-2026) & (M Units) Table 159. Asia-Pacific Normal Saline for Parenteral Use Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Normal Saline for Parenteral Use Sales Forecast by Country (2027-2032) & (M Units) Table 161. Asia-Pacific Normal Saline for Parenteral Use Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Normal Saline for Parenteral Use Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Normal Saline for Parenteral Use Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Normal Saline for Parenteral Use Market Share by Country (2021-2026) Table 165. Asia-Pacific Normal Saline for Parenteral Use Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Normal Saline for Parenteral Use Market Share Forecast by Country (2027-2032) Table 167. Latin America Normal Saline for Parenteral Use Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 168. Latin America Normal Saline for Parenteral Use Sales by Country (2021-2026) & (M Units) Table 169. Latin America Normal Saline for Parenteral Use Sales Market Share by Country (2021-2026) Table 170. Latin America Normal Saline for Parenteral Use Sales Forecast by Country (2027-2032) & (M Units) Table 171. Latin America Normal Saline for Parenteral Use Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Normal Saline for Parenteral Use Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Normal Saline for Parenteral Use Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Normal Saline for Parenteral Use Market Share by Country (2021-2026) Table 175. Latin America Normal Saline for Parenteral Use Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Normal Saline for Parenteral Use Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Normal Saline for Parenteral Use Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Normal Saline for Parenteral Use Sales by Country (2021-2026) & (M Units) Table 179. Middle East and Africa Normal Saline for Parenteral Use Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Normal Saline for Parenteral Use Sales Forecast by Country (2027-2032) & (M Units) Table 181. Middle East and Africa Normal Saline for Parenteral Use Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Normal Saline for Parenteral Use Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Normal Saline for Parenteral Use Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Normal Saline for Parenteral Use Market Share by Country (2021-2026) Table 185. Middle East and Africa Normal Saline for Parenteral Use Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Normal Saline for Parenteral Use Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Normal Saline for Parenteral Use Distributors List Table 190. Normal Saline for Parenteral Use Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Normal Saline for Parenteral Use Image Figure 2. Global Normal Saline for Parenteral Use Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Normal Saline for Parenteral Use Market Size (2021-2032) & (US$ Million) Figure 4. Global Normal Saline for Parenteral Use Sales (2021-2032) & (M Units) Figure 5. Flexible Bag Image Figure 6. Global Flexible Bag Sales YoY Growth (2021-2032) & (M Units) Figure 7. Plastic Bottles Image Figure 8. Global Plastic Bottles Sales YoY Growth (2021-2032) & (M Units) Figure 9. Glass Bottles Image Figure 10. Global Glass Bottles Sales YoY Growth (2021-2032) & (M Units) Figure 11. Global Normal Saline for Parenteral Use Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Normal Saline for Parenteral Use Market Share by Type 2025 VS 2032 Figure 13. North America Normal Saline for Parenteral Use Sales Market Share in Volume by Type in 2025 Figure 14. North America Normal Saline for Parenteral Use Sales Market Share in Value by Type in 2025 Figure 15. Europe Normal Saline for Parenteral Use Sales Market Share in Volume by Type in 2025 Figure 16. Europe Normal Saline for Parenteral Use Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Normal Saline for Parenteral Use Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Normal Saline for Parenteral Use Sales Market Share in Value by Type in 2025 Figure 19. Latin America Normal Saline for Parenteral Use Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Normal Saline for Parenteral Use Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Normal Saline for Parenteral Use Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Normal Saline for Parenteral Use Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Normal Saline for Parenteral Use Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Intramuscular Injection Image Figure 26. Global Intramuscular Injection Sales YoY Growth (2021-2032) & (M Units) Figure 27. Intravenous Injection Image Figure 28. Global Intravenous Injection Sales YoY Growth (2021-2032) & (M Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 31. Global Normal Saline for Parenteral Use Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Normal Saline for Parenteral Use Market Share by Application 2025 VS 2032 Figure 33. North America Normal Saline for Parenteral Use Sales Market Share in Volume by Application in 2025 Figure 34. North America Normal Saline for Parenteral Use Sales Market Share in Value by Application in 2025 Figure 35. Europe Normal Saline for Parenteral Use Sales Market Share in Volume by Application in 2025 Figure 36. Europe Normal Saline for Parenteral Use Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Normal Saline for Parenteral Use Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Normal Saline for Parenteral Use Sales Market Share in Value by Application in 2025 Figure 39. Latin America Normal Saline for Parenteral Use Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Normal Saline for Parenteral Use Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Normal Saline for Parenteral Use Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Normal Saline for Parenteral Use Sales Market Share in Value by Application in 2025 Figure 43. North America Normal Saline for Parenteral Use Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 44. North America Normal Saline for Parenteral Use Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Normal Saline for Parenteral Use Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Normal Saline for Parenteral Use Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Normal Saline for Parenteral Use Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 48. Europe Normal Saline for Parenteral Use Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Normal Saline for Parenteral Use Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Normal Saline for Parenteral Use Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Normal Saline for Parenteral Use Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 52. Asia-Pacific Normal Saline for Parenteral Use Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Normal Saline for Parenteral Use Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Normal Saline for Parenteral Use Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Normal Saline for Parenteral Use Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 56. Latin America Normal Saline for Parenteral Use Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Normal Saline for Parenteral Use Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Normal Saline for Parenteral Use Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Normal Saline for Parenteral Use Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 60. Middle East and Africa Normal Saline for Parenteral Use Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Normal Saline for Parenteral Use Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Normal Saline for Parenteral Use Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Normal Saline for Parenteral Use Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Normal Saline for Parenteral Use Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Flexible Bag
  • Plastic Bottles
  • Glass Bottles
Applications
  • Intramuscular Injection
  • Intravenous Injection
  • Others
Companies covered
  • Baxter
  • Pfizer
  • B. Braun
  • ICU Medical
  • Fresenius Kabi
  • Otsuka
  • Kelun Group
  • CR Double-Cran
  • SSY Group
  • Cisen Pharmaceutical
  • Denis Chem Lab Limited
  • Shree Krishnakeshav Laboratories
  • Pharmally International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Normal Saline for Parenteral Use Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Normal Saline for Parenteral Use Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Normal Saline for Parenteral Use Market by Type
  6. 1.3.1 Flexible Bag
  7. 1.3.2 Plastic Bottles
  8. 1.3.3 Glass Bottles
  9. 1.4 Global Normal Saline for Parenteral Use Market Size by Type
  10. 1.4.1 Global Normal Saline for Parenteral Use Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Normal Saline for Parenteral Use Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Normal Saline for Parenteral Use Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Normal Saline for Parenteral Use Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Normal Saline for Parenteral Use Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Normal Saline for Parenteral Use Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Normal Saline for Parenteral Use Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Normal Saline for Parenteral Use Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Normal Saline for Parenteral Use Industry Trends
  2. 2.2 Normal Saline for Parenteral Use Industry Drivers
  3. 2.3 Normal Saline for Parenteral Use Industry Opportunities and Challenges
  4. 2.4 Normal Saline for Parenteral Use Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Normal Saline for Parenteral Use Revenue (2021-2026)
  2. 3.2 Global Top Players by Normal Saline for Parenteral Use Sales (2021-2026)
  3. 3.3 Global Top Players by Normal Saline for Parenteral Use Price (2021-2026)
  4. 3.4 Global Normal Saline for Parenteral Use Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Normal Saline for Parenteral Use Major Company Production Sites & Headquarters
  6. 3.6 Global Normal Saline for Parenteral Use Company, Product Type & Application
  7. 3.7 Global Normal Saline for Parenteral Use Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Normal Saline for Parenteral Use Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Normal Saline for Parenteral Use Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Normal Saline for Parenteral Use Tier 1, Tier 2, and Tier 3
4 Normal Saline for Parenteral Use Regional Status and Outlook
  1. 4.1 Global Normal Saline for Parenteral Use Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Normal Saline for Parenteral Use Historic Market Size by Region
  3. 4.2.1 Global Normal Saline for Parenteral Use Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Normal Saline for Parenteral Use Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Normal Saline for Parenteral Use Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Normal Saline for Parenteral Use Forecasted Market Size by Region
  7. 4.3.1 Global Normal Saline for Parenteral Use Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Normal Saline for Parenteral Use Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Normal Saline for Parenteral Use Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Normal Saline for Parenteral Use by Application
  1. 5.1 Normal Saline for Parenteral Use Market by Application
  2. 5.1.1 Intramuscular Injection
  3. 5.1.2 Intravenous Injection
  4. 5.1.3 Others
  5. 5.2 Global Normal Saline for Parenteral Use Market Size by Application
  6. 5.2.1 Global Normal Saline for Parenteral Use Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Normal Saline for Parenteral Use Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Normal Saline for Parenteral Use Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Normal Saline for Parenteral Use Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Normal Saline for Parenteral Use Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Normal Saline for Parenteral Use Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Normal Saline for Parenteral Use Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Normal Saline for Parenteral Use Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Baxter
  2. 6.1.1 Baxter Company Information
  3. 6.1.2 Baxter Business Overview
  4. 6.1.3 Baxter Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Baxter Normal Saline for Parenteral Use Product Portfolio
  6. 6.1.5 Baxter Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Normal Saline for Parenteral Use Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 B. Braun
  14. 6.3.1 B. Braun Company Information
  15. 6.3.2 B. Braun Business Overview
  16. 6.3.3 B. Braun Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 B. Braun Normal Saline for Parenteral Use Product Portfolio
  18. 6.3.5 B. Braun Recent Developments
  19. 6.4 ICU Medical
  20. 6.4.1 ICU Medical Company Information
  21. 6.4.2 ICU Medical Business Overview
  22. 6.4.3 ICU Medical Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 ICU Medical Normal Saline for Parenteral Use Product Portfolio
  24. 6.4.5 ICU Medical Recent Developments
  25. 6.5 Fresenius Kabi
  26. 6.5.1 Fresenius Kabi Company Information
  27. 6.5.2 Fresenius Kabi Business Overview
  28. 6.5.3 Fresenius Kabi Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Fresenius Kabi Normal Saline for Parenteral Use Product Portfolio
  30. 6.5.5 Fresenius Kabi Recent Developments
  31. 6.6 Otsuka
  32. 6.6.1 Otsuka Company Information
  33. 6.6.2 Otsuka Business Overview
  34. 6.6.3 Otsuka Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Otsuka Normal Saline for Parenteral Use Product Portfolio
  36. 6.6.5 Otsuka Recent Developments
  37. 6.7 Kelun Group
  38. 6.7.1 Kelun Group Company Information
  39. 6.7.2 Kelun Group Business Overview
  40. 6.7.3 Kelun Group Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Kelun Group Normal Saline for Parenteral Use Product Portfolio
  42. 6.7.5 Kelun Group Recent Developments
  43. 6.8 CR Double-Cran
  44. 6.8.1 CR Double-Cran Company Information
  45. 6.8.2 CR Double-Cran Business Overview
  46. 6.8.3 CR Double-Cran Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 CR Double-Cran Normal Saline for Parenteral Use Product Portfolio
  48. 6.8.5 CR Double-Cran Recent Developments
  49. 6.9 SSY Group
  50. 6.9.1 SSY Group Company Information
  51. 6.9.2 SSY Group Business Overview
  52. 6.9.3 SSY Group Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 SSY Group Normal Saline for Parenteral Use Product Portfolio
  54. 6.9.5 SSY Group Recent Developments
  55. 6.10 Cisen Pharmaceutical
  56. 6.10.1 Cisen Pharmaceutical Company Information
  57. 6.10.2 Cisen Pharmaceutical Business Overview
  58. 6.10.3 Cisen Pharmaceutical Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Cisen Pharmaceutical Normal Saline for Parenteral Use Product Portfolio
  60. 6.10.5 Cisen Pharmaceutical Recent Developments
  61. 6.11 Denis Chem Lab Limited
  62. 6.11.1 Denis Chem Lab Limited Company Information
  63. 6.11.2 Denis Chem Lab Limited Business Overview
  64. 6.11.3 Denis Chem Lab Limited Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Denis Chem Lab Limited Normal Saline for Parenteral Use Product Portfolio
  66. 6.11.5 Denis Chem Lab Limited Recent Developments
  67. 6.12 Shree Krishnakeshav Laboratories
  68. 6.12.1 Shree Krishnakeshav Laboratories Company Information
  69. 6.12.2 Shree Krishnakeshav Laboratories Business Overview
  70. 6.12.3 Shree Krishnakeshav Laboratories Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Shree Krishnakeshav Laboratories Normal Saline for Parenteral Use Product Portfolio
  72. 6.12.5 Shree Krishnakeshav Laboratories Recent Developments
  73. 6.13 Pharmally International
  74. 6.13.1 Pharmally International Company Information
  75. 6.13.2 Pharmally International Business Overview
  76. 6.13.3 Pharmally International Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Pharmally International Normal Saline for Parenteral Use Product Portfolio
  78. 6.13.5 Pharmally International Recent Developments
7 North America by Country
  1. 7.1 North America Normal Saline for Parenteral Use Sales by Country
  2. 7.1.1 North America Normal Saline for Parenteral Use Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Normal Saline for Parenteral Use Sales by Country (2021-2026)
  4. 7.1.3 North America Normal Saline for Parenteral Use Sales Forecast by Country (2027-2032)
  5. 7.2 North America Normal Saline for Parenteral Use Market Size by Country
  6. 7.2.1 North America Normal Saline for Parenteral Use Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Normal Saline for Parenteral Use Market Size by Country (2021-2026)
  8. 7.2.3 North America Normal Saline for Parenteral Use Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Normal Saline for Parenteral Use Sales by Country
  2. 8.1.1 Europe Normal Saline for Parenteral Use Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Normal Saline for Parenteral Use Sales by Country (2021-2026)
  4. 8.1.3 Europe Normal Saline for Parenteral Use Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Normal Saline for Parenteral Use Market Size by Country
  6. 8.2.1 Europe Normal Saline for Parenteral Use Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Normal Saline for Parenteral Use Market Size by Country (2021-2026)
  8. 8.2.3 Europe Normal Saline for Parenteral Use Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Normal Saline for Parenteral Use Sales by Country
  2. 9.1.1 Asia-Pacific Normal Saline for Parenteral Use Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Normal Saline for Parenteral Use Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Normal Saline for Parenteral Use Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Normal Saline for Parenteral Use Market Size by Country
  6. 9.2.1 Asia-Pacific Normal Saline for Parenteral Use Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Normal Saline for Parenteral Use Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Normal Saline for Parenteral Use Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Normal Saline for Parenteral Use Sales by Country
  2. 10.1.1 South America Normal Saline for Parenteral Use Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Normal Saline for Parenteral Use Sales by Country (2021-2026)
  4. 10.1.3 South America Normal Saline for Parenteral Use Sales Forecast by Country (2027-2032)
  5. 10.2 South America Normal Saline for Parenteral Use Market Size by Country
  6. 10.2.1 South America Normal Saline for Parenteral Use Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Normal Saline for Parenteral Use Market Size by Country (2021-2026)
  8. 10.2.3 South America Normal Saline for Parenteral Use Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Normal Saline for Parenteral Use Sales by Country
  2. 11.1.1 Middle East and Africa Normal Saline for Parenteral Use Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Normal Saline for Parenteral Use Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Normal Saline for Parenteral Use Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Normal Saline for Parenteral Use Market Size by Country
  6. 11.2.1 Middle East and Africa Normal Saline for Parenteral Use Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Normal Saline for Parenteral Use Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Normal Saline for Parenteral Use Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Normal Saline for Parenteral Use Value Chain Analysis
  2. 12.1.1 Normal Saline for Parenteral Use Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Normal Saline for Parenteral Use Production Mode & Process
  7. 12.2 Normal Saline for Parenteral Use Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Normal Saline for Parenteral Use Distributors
  10. 12.2.3 Normal Saline for Parenteral Use Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst